Human medicines European public assessment report (EPAR): Firmagon, degarelix, Prostatic Neoplasms, Date of authorisation: 17/02/2009, Revision: 14, Status: Authorised

Case Medical Research ◽

10.31525/cmr-267ec3a ◽

2020 ◽

Author(s):

Keyword(s):

Prostatic Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Taxespira (previously Docetaxel Hospira UK Limited ), docetaxel, Stomach Neoplasms,Prostatic Neoplasms,Breast Neoplasms,Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung, Date of authorisation: 28/08/2015, Revision: 8, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-1f52484 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Stomach Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Taxotere, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 27/11/1995, Revision: 44, Status: Authorised

Case Medical Research ◽

10.31525/cmr-ea7c28 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Lung Adenocarcinoma ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Docetaxel Accord, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Breast Neoplasms, Date of authorisation: 22/05/2012, Revision: 12, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871e0 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Lung Adenocarcinoma ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Docetaxel Accord, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Breast Neoplasms, Date of authorisation: 21/05/2012, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-543dab ◽

2018 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Lung Adenocarcinoma ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Docetaxel Zentiva (previously Docetaxel Winthrop), docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 20/04/2007, Revision: 30, Status: Authorised

Case Medical Research ◽

10.31525/cmr-bc1105 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Lung Adenocarcinoma ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Docetaxel Teva, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 26/01/2010, Revision: 17, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1971609 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Lung Adenocarcinoma ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Docetaxel Kabi, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Breast Neoplasms, Date of authorisation: 22/05/2012, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-116dee2 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Lung Adenocarcinoma ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Zytiga, abiraterone, Prostatic Neoplasms, Date of authorisation: 05/09/2011, Revision: 21, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d7cc2b ◽

2019 ◽

Author(s):

Keyword(s):

Prostatic Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Taxotere, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 27/11/1995, Revision: 44, Status: Authorised

Case Medical Research ◽

10.31525/cmr-ea2d10 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Lung Adenocarcinoma ◽

Head And Neck ◽

Prostatic Neoplasms ◽

Head And Neck Neoplasms ◽

Small Cell Lung ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Erleada, apalutamide, Prostatic Neoplasms, Date of authorisation: 14/01/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-e0265a ◽

2019 ◽

Author(s):

Keyword(s):

Prostatic Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text